Browsing by Author "Küçük, Özlem Su"

Now showing items 1-3 of 3

Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis

Çakıter, Alkım Ünal; Küçük, Özlem Su; Bıyık Özkaya, Dilek; Topukçu, Buğçe; Onsun, Nahide (Termedia Publishing House Ltd., 2017)

Introduction: Vasculitides are a heterogeneous group of disease characterized by inflammation of the blood vessel walls. Etiological factors include infections, drugs, connective tissue diseases, and malignancies.Aim: To ...
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

Kocatürk, Emek; Bülbül Başkan, Emel; Engin, Betül Hacer; Özdemir, Mehmet Akif; Küçük, Özlem Su; Can, Pelin; Örnek, Seçil; Hasal, Eda; Atakan, Nilgün (Wiley, 2019)

...
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Can we define better-responding endotypes?

Kocatürk, Emek; Bülbül Başkan, Emel; Küçük, Özlem Su; Özdemir, Mustafa; Örnek, Sinem; Can, Pelin Kuteyla; Haşal, Eda; Engin, Burhan; Atakan, Nilgün; Alpsoy, Erkan (Elsevier Science Inc, 2022)

Background: Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line ...